HRID1677207

反应详情

EQUATION

反应方程式

HRID 1677207 的结构方程式

AUXILIARIES

试剂、催化剂与溶剂

1

PROCEDURE

实验过程

Antagonist activity of selected compounds was tested for inhibition of [35S] GTP γ [S] binding to H3R membranes in the presence of agonists. Assays were run at room temperature in 20 mM HEPES, 100 mM NaCl, 5 mM MgCl2 and 10 uM GDP at pH 7.4 in a final volume of 200 ul in 96-well Costar plates. Membranes isolated from H3R8-expressing HEK293 cell line (20 ug/well) and GDP were added to each well in a volume of 50 μl assay buffer. Antagonist was then added to the wells in a volume of 50 μl assay buffer and incubated for 15 minutes at room temperature. Agonist R(−)alpha methylhistamine (RBI) at either a dose response from 1×10−10 to 1A1-5 M or fixed concentration of 100 nM were then added to the wells in a volume of 50 μl assay buffer and incubated for 5 minutes at room temperature. GTP γ [35S] was added to each well in a volume of 50 μl assay buffer at a final concentration of 200 pM, followed by the addition of 50 μl of 20 mg/ml WGA coated SPA beads (Amersham). Plates were counted in Wallac Trilux 1450 Microbeta scintillation counter for 1 minute. Compounds that inhibited more than 50% of the specific binding of radioactive ligand to the receptor were serially diluted to determine a K[i](nM). The results are given below for the indicated compound.

WORKUP

后处理

  1. customMembranes isolated from H3R8-expressing HEK293 cell line (20 ug/well) and GDP
  2. additionwere added to each well in a volume of 50 μl assay buffer
  3. additionAntagonist was then added to the wells in a volume of 50 μl assay buffer and
  4. waitincubated for 5 minutes at room temperature
  5. additionwas added to each well in a volume of 50 μl assay buffer at a final concentration of 200 pM
  6. additionfollowed by the addition of 50 μl of 20 mg/ml WGA coated SPA beads (Amersham)
  7. waitPlates were counted in Wallac Trilux 1450 Microbeta scintillation counter for 1 minute
  8. additionwere serially diluted